Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Ardelyx Inc. | 2 | 0 | 0 | 0 | €7.22 | €11.00 | 52.397% |
| Chromadex Corp | 11 | 2 | 1 | 0 | €3.42 | €5.58 | 63.035% |
| Pfizer Inc. | 31 | 4 | 3 | 0 | €26.01 | €41.10 | 58.028% |
| Evolus Inc | 9 | 0 | 3 | 0 | €11.90 | €20.43 | 71.702% |
| Immunic Inc. | 6 | 3 | 0 | 2 | €1.18 | €5.48 | 364.953% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.35 | - | - |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €7.75 | €8.75 | 12.903% |
| Krystal Biotech | 17 | 0 | 3 | 0 | €145.65 | €179.60 | 23.306% |
| Medpace Holdings Inc | 9 | 0 | 3 | 0 | €362.30 | €421.61 | 16.369% |
| Novocure Ltd | 1 | 1 | 0 | 0 | €15.32 | - | - |
| Stoke Therapeutics Inc | 15 | 1 | 3 | 0 | €11.10 | €21.00 | 89.222% |
| Iovance Biotherapeutics Inc. | 20 | 3 | 1 | 0 | €10.18 | €25.20 | 147.572% |
| Personalis Inc | 7 | 0 | 3 | 0 | €1.50 | €3.25 | 117.275% |
| XOMA Corp. | 6 | 0 | 3 | 0 | €22.20 | €68.78 | 209.817% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| United Therapeutics | 18 | 0 | 3 | 0 | €245.40 | €288.66 | 17.629% |
| Precision BioSciences Inc | 7 | 0 | 1 | 0 | €0.35 | €2.90 | 734.167% |
| aTyr Pharma Inc | 2 | 0 | 1 | 0 | €1.57 | €10.00 | 536.943% |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.00 | €47.53 | 76.030% |
| Taro Pharmaceutical Industries Ltd | 8 | 0 | 2 | 0 | €39.20 | - | - |
| Kala Pharmaceuticals Inc. | 4 | 0 | 0 | 0 | €6.26 | €19.86 | 217.331% |
| Regeneron Pharmaceuticals Inc. | 34 | 1 | 5 | 1 | €903.60 | €957.22 | 5.934% |
| GSK plc ADR | 4 | 0 | 0 | 0 | €42.00 | - | - |
| G1 Therapeutics | 15 | 1 | 3 | 0 | €4.44 | €10.56 | 137.922% |
| MPH Health Care AG | 1 | 0 | 0 | 0 | €25.00 | - | - |